Copyright
©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1421-1437
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1421
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1421
Table 2 Rebleed rates at 5 days and 42 days, and mortality at 42 days in cirrhosis patients with platelet counts < 20 × 109/L, 20-50 × 109/L and > 50 × 109/L
Characteristics | Total (n = 913) | Platelet count < 20 × 109/L (n = 23) | Platelet count 20-50 × 109/L (n = 168) | Platelet count > 50 × 109/L (n = 722) | P value |
Rebleed at 5 d | 48 (5.3) | 3 (13.0) | 11 (6.5) | 34 (4.7) | 0.150 |
Rebleed at 42 d | 138 (15.1) | 5 (21.7) | 29 (17.3) | 104 (14.4) | 0.433 |
Death at 42 d | 166 (18.2) | 3 (13.0) | 39 (23.2) | 124 (17.2) | 0.153 |
- Citation: Biswas S, Vaishnav M, Pathak P, Gunjan D, Mahapatra SJ, Kedia S, Rout G, Thakur B, Nayak B, Kumar R, Shalimar. Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease. World J Hepatol 2022; 14(7): 1421-1437
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1421.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1421